Trial intelligence / Profile preview

anaGO: Anakinra in Acute Gouty Arthritis

NCT03002974Phase 2Completed

Sponsor
Sobi
Start
Dec 2016
Primary completion
Jun 2018
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in acute gouty arthritis, sponsored by Sobi. Started Dec 2016; status: completed.

02

Drugs

anakinra
03

Conditions

acute gouty arthritis

Beyond the preview

Go deeper on NCT03002974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03002974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call